ELV Elevance Health Inc

Price (delayed)

$527.5

Market cap

$122.32B

P/E Ratio

18.37

Dividend/share

$6.22

EPS

$28.72

Enterprise value

$143.51B

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately ...

Highlights
The equity has increased by 10% YoY and by 3.9% from the previous quarter
Elevance Health's EPS has increased by 8% YoY and by 8% QoQ
ELV's P/E is 3.5% above its 5-year quarterly average of 17.3 but 3.2% below its last 4 quarters average of 18.5
Elevance Health's debt has increased by 10% YoY and by 4.7% from the previous quarter

Key stats

What are the main financial stats of ELV
Market
Shares outstanding
231.89M
Market cap
$122.32B
Enterprise value
$143.51B
Valuations
Price to book (P/B)
2.91
Price to sales (P/S)
0.71
EV/EBIT
14.87
EV/EBITDA
12.85
EV/Sales
0.83
Earnings
Revenue
$171.96B
EBIT
$9.65B
EBITDA
$11.17B
Free cash flow
$820M
Per share
EPS
$28.72
Free cash flow per share
$3.53
Book value per share
$181.53
Revenue per share
$739.87
TBVPS
$329.49
Balance sheet
Total assets
$112.99B
Total liabilities
$70.69B
Debt
$27.69B
Equity
$42.19B
Working capital
$20.46B
Liquidity
Debt to equity
0.66
Current ratio
1.49
Quick ratio
1.32
Net debt/EBITDA
1.9
Margins
EBITDA margin
6.5%
Gross margin
17.9%
Net margin
3.9%
Operating margin
5.6%
Efficiency
Return on assets
6%
Return on equity
16.7%
Return on invested capital
19.1%
Return on capital employed
13.6%
Return on sales
5.6%
Dividend
Dividend yield
1.18%
DPS
$6.22
Payout ratio
21.7%

ELV stock price

How has the Elevance Health stock price performed over time
Intraday
2.62%
1 week
5.47%
1 month
-1.28%
1 year
12.33%
YTD
11.86%
QTD
-2.65%

Financial performance

How have Elevance Health's revenue and profit performed over time
Revenue
$171.96B
Gross profit
$30.77B
Operating income
$9.64B
Net income
$6.69B
Gross margin
17.9%
Net margin
3.9%
Elevance Health's net margin has increased by 8% from the previous quarter and by 2.6% YoY
ELV's gross profit is up by 7% year-on-year and by 2.5% since the previous quarter
Elevance Health's net income has increased by 7% QoQ and by 6% YoY
The operating income has grown by 6% from the previous quarter and by 5% YoY

Growth

What is Elevance Health's growth rate over time

Valuation

What is Elevance Health stock price valuation
P/E
18.37
P/B
2.91
P/S
0.71
EV/EBIT
14.87
EV/EBITDA
12.85
EV/Sales
0.83
Elevance Health's EPS has increased by 8% YoY and by 8% QoQ
ELV's P/E is 3.5% above its 5-year quarterly average of 17.3 but 3.2% below its last 4 quarters average of 18.5
The equity has increased by 10% YoY and by 3.9% from the previous quarter
ELV's price to book (P/B) is 4.8% higher than its 5-year quarterly average of 2.7 but 2.4% lower than its last 4 quarters average of 2.9
The company's revenue rose by 3.8% YoY

Efficiency

How efficient is Elevance Health business performance
Elevance Health's return on sales has increased by 6% QoQ
Elevance Health's ROIC has decreased by 6% YoY
Elevance Health's return on assets has increased by 5% QoQ
ELV's ROE is up by 4.4% QoQ but it is down by 2.3% YoY

Dividends

What is ELV's dividend history
DPS
$6.22
Dividend yield
1.18%
Payout ratio
21.7%
Recent dividends

Financial health

How did Elevance Health financials performed over time
The total assets is 60% higher than the total liabilities
The current ratio rose by 9% QoQ and by 3.5% YoY
ELV's quick ratio is up by 7% since the previous quarter
Elevance Health's debt is 34% less than its equity
Elevance Health's debt has increased by 10% YoY and by 4.7% from the previous quarter
The equity has increased by 10% YoY and by 3.9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.